Assessing the risk and costs of COVID-19 in immunocompromised populations in a large United States commercial insurance health plan: the EPOCH-US Study

Amita Ketkar, Vincent Willey, Michael Pollack, Lisa Glasser, Casey Dobie, Cachet Wenziger, Chia Chen Teng, Christine Dube, Dennis Cunningham, Monica Verduzco-Gutierrez

Producción científica: Articlerevisión exhaustiva

8 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Assessing the risk and costs of COVID-19 in immunocompromised populations in a large United States commercial insurance health plan: the EPOCH-US Study'. En conjunto forman una huella única.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science